Dawid G. Nowak
Affiliations: | 2005-2008 | Department of Physiology | University of Bristol, Bristol, England, United Kingdom |
Google:
"Dawid Nowak"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nowak DG, Katsenelson KC, Watrud KE, et al. (2019) The PHLPP2 phosphatase is a druggable driver of prostate cancer progression. The Journal of Cell Biology |
| D'Andrea V, Nowak D, Watrud K, et al. (2018) Abstract 1097: The Phlpp2 phosphatase protects Myc and is a target for the prevention of prostate cancer metastasis Cancer Research. 78: 1097-1097 |
| Chen M, Nowak DG, Narula N, et al. (2017) The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein. The Journal of Cell Biology |
| Nowak DG, Cho H, Herzka T, et al. (2015) MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2. Cancer Discovery. 5: 636-51 |
| Nowak DG, Cho H, Herzka T, et al. (2015) Abstract 2258: Myc drives Pten/ p53-deficient proliferation and metastasis due to Il6-secretion and Akt-suppression via Phlpp2 Cancer Research. 75: 2258-2258 |
| Reyes G, Niederst M, Cohen-Katsenelson K, et al. (2014) Pleckstrin homology domain leucine-rich repeat protein phosphatases set the amplitude of receptor tyrosine kinase output. Proceedings of the National Academy of Sciences of the United States of America. 111: E3957-65 |
| Chen M, Nowak DG, Trotman LC. (2014) Molecular pathways: PI3K pathway phosphatases as biomarkers for cancer prognosis and therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3057-63 |
| Woolard J, Vousden W, Moss SJ, et al. (2011) Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms. Chemical Science (Royal Society of Chemistry : 2010). 2011: 273-278 |
| Amin EM, Oltean S, Hua J, et al. (2011) WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. Cancer Cell. 20: 768-80 |
| Chen M, Pratt CP, Zeeman ME, et al. (2011) Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression. Cancer Cell. 20: 173-86 |